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Pharmacy practiceAbstract Introduction: Pharmacy is a very dynamic profession and the role of the pharmacist is
improving with the expansion of the scope of services and the introduction of new subspecialties
over time. Moving from being medication dispensers to outcome-oriented and patient-focused care
providers; pharmacists will carry more responsibility and commitment to improve their knowledge
and practice.
Being updated and evidence-based is a key tool to achieve effective pharmaceutical care services.
The primary purpose of this article is to highlight the concept of ‘‘evidence based pharmaceutical
care’’ as professional practice to improve the quality of pharmaceutical care.
Methods: Literature for relevant evidence was searched by Medline (through PubMed),
Cochrane library using the keywords: pharmaceutical care, evidence-based and pharmacy practice.
Also a manual search through major journals for articles referenced in those located through
PubMed was done.
Results and discussion: There is strong data showing that pharmaceutical care lead to improve-
ment in health outcomes and cost-effective therapy. More efforts, policies and qualiﬁed staff are
needed to establish the ‘‘evidence-based pharmaceutical care’’ as new daily professional practice.
Evidence to support pharmacists in their emerging role as care providers is available to improve
the efﬁcacy and quality of pharmaceutical care. Education and specialized training practicing evi-
dence based approach are vital to prepare pharmacists to provide high quality pharmaceutical care.
Conclusion: As care providers, pharmacists are effective in providing high quality patient care and
being members in multidisciplinary clinical teams is needed to give them the opportunity. Evidence
based pharmaceutical care is a natural and logical emerging concept in themodern pharmacy practice
to achieve high quality andmore effective pharmaceutical care but still more efforts and resources are
needed to promote new attitude toward more professional career.
ª 2014 Production and hosting by Elsevier B.V. on behalf of King Saud University. This is an open access
article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).
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Personal experience or expert opinion alone is not enough to
support health care decision. High quality research is the most
accurate source of scientiﬁc evidence that can be used to iden-
tify and meet the patient health needs. In a recent survey of
pharmacists, 90% held positive attitudes toward evidence
based practice and 84% thought research ﬁndings were impor-
tant to daily practice (Burkiewicz and Zgarrick, 2005). These
results reﬂect the awareness of the pharmacists toward their
profession as evidence-based practice and the desire to expand
their role as researchers.
Pharmacy profession has improved to include the provision
of cognitive services in addition to the traditional role of med-
ication dispensing. Establishing evidence-based practice is
important for pharmaceutical care services to be effective,
updated and relevant to patients. Pharmacists must accept
and actively participate in the research needed to establish
the required evidence-base pharmaceutical care.
1.1. What is ‘‘pharmaceutical care’’?
According to the deﬁnition of Hepler & Strand pharmaceutical
care is ‘‘the responsible provision of drug therapy for the pur-
pose of achieving deﬁnite outcomes that improve a patient’s
quality of life’’ (Hepler and Strand, 1990). Pharmaceutical care
is based on a relationship between the patient and the health-
care providers who accept responsibility to provide care to the
patients. Pharmaceutical care involves the active participation
of both the patient and the health care provider in drug ther-
apy decisions.
Pharmaceutical care involves three major functions: identi-
fying potential and actual drug related problems; resolving
actual drug-related problems; and preventing drug related
problems. Although there are different trends, such as clinical
pharmacy services, cognitive services, medication manage-
ment, medication review, they all share the same philosophy
and objectives, namely ‘‘the responsible provision of drug
therapy for the purpose of achieving deﬁnite outcomesthat improve a patient’s quality of life’’ (Roughead et al.,
1990).
Pharmaceutical care activities include medication dispens-
ing, providing drug information, patient counseling, drug
monitoring, parenteral nutrition preparation, adverse drug
reaction monitoring, medication reconciliation, drug proto-
col/guideline development, medical rounding with the health
care team, and performing admission drug histories. Practicing
these activities by evidence-based approach will improve the
quality of the provided services.
Pharmacists need training and support to develop and
improve their practical skills to provide comprehensive phar-
maceutical care (Schommer and Cable, 1996).
To be effective, pharmaceutical care needs to be adopted by
majority of pharmacists in their daily work. Many barriers
limit the implementation of the pharmaceutical care principles.
To identify and solve these barriers well designed research is
needed (Farris and Kirking, 1993a,b).
1.2. Evidence based practice
There is an increasing awareness of the need for healthcare
professionals to adopt an evidence-based approach to their
daily practice. Practicing pharmacy in an evidence based man-
ner will enhance professional skills of the pharmacist with
improved patient care. The concept of evidence-based pharma-
ceutical care requires training and education starting from
undergraduate level. Pharmacy students need to be educated
how to professionally apply science in patient care. Special
training on research principles, literature review and evidence
based approaches is very important to prepare the pharmacists
to practice the evidence based pharmaceutical care efﬁciently.
2. Methods
A literature review was performed by searching Medline data-
base through PubMed for relevant articles including meta-
analyses, systematic reviews, review articles, randomized and
non-randomized trials, as well as case reports. Search
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care, pharmacist, pharmaceutical care, and pharmacy practice.
Web-based searching and backward citation tracking were
conducted for context and additional citations.
3. Results and discussion
3.1. Search results
There are strong data showing that pharmaceutical care is
effective and led to improved patient care with more cost-
effective therapy in both in- and outpatient settings. Many
studies and reviews demonstrated the efﬁcacy of the pharma-
ceutical care programs as described below. Research describing
the term ‘‘evidence-based pharmaceutical care’’ is limited in
the literature.
3.2. Data ﬁndings
3.2.1. Inpatient pharmaceutical care
The literature proving the beneﬁcial role of the pharmacist in
inpatient care is strong and abundant (Shekelle et al., 2013).
A comprehensive systematic review of inpatient pharmacy ser-
vices was conducted and summarized in a Technology Assess-
ment report in 2013 by the Agency for Healthcare Research
and Quality titled, ‘‘Making Healthcare Safer II: an Updated
Critical Analysis of the Evidence for Patient Safety Practices’’.
The report stated that the totality of the literature (delin-
eated in evidence tables) shows that pharmacist-provided care
enhances the patient safety and improves outcomes. Later in
the report, they focus on medication reconciliation and found
that pharmacists signiﬁcantly decreased emergency depart-
ment visits and hospitalizations within 30 days of discharge
(Shekelle et al., 2013).
Services provided by pharmacists in hospitals were found
to be highly cost-effective in a database analysis of 1016 hos-
pitals (Bond et al., 2000). In all, 6 services signiﬁcantly
reduced costs, including drug use evaluation, drug informa-
tion, adverse drug reaction monitoring, drug protocol/
guideline development, medical rounding with the health care
team, and performing admission drug histories. As stafﬁng
was increased for clinical pharmacists, total cost of care
decreased (Bond et al., 2000).
3.2.2. Outpatient pharmaceutical care
In 2010, a comprehensive systematic review of 298 studies eval-
uating the impact of pharmacist-provided direct patient care in
ambulatory settings found signiﬁcant beneﬁts in achieving
hemoglobin A1c, LDL cholesterol, and blood pressure targets
in addition to reducing adverse drug events (Chisolm-Burns
et al., 2010). These intermediate health outcome beneﬁts result
from enhanced patient knowledge about medications,
increased medication adherence, and improved quality of life
as a result of pharmacist-provided services (Chisolm-Burns
et al., 2010).
In a systematic review of 15 randomized controlled trials in
9111 outpatients with diabetes published in 2012, the use of
pharmacist medication management, educational interven-
tions, feedback to providers, and patient reminders had asigniﬁcant effect on systolic blood pressure, diastolic blood
pressure, total cholesterol, LDL cholesterol, and body mass
index versus standard of care (Santschi et al., 2012).
Similar beneﬁts were seen in a systematic review of hyper-
lipidemia patients treated by pharmacists, where markers of
lipid control were markedly improved (Charrois et al.,
2012). In July 2013, the impact of pharmacists, speciﬁcally
on geriatric care, was assessed in a meta-analysis of 20 studies
(Lee et al., 2013). Pharmacist-provided care resulted in
signiﬁcant improvements in hospitalizations, medication
adherence, combined therapeutic outcomes (blood pressure,
INRs, etc), and combined safety end points (falls, adverse
events, and number of unnecessary drugs being used) (Lee
et al., 2013).
3.2.3. Evidence-based pharmaceutical care
The concept ‘‘evidence-based pharmaceutical care’’ has been
mentioned as a term in 2008 (Gaebelein and Gleason, 2008)
and it has been deﬁned in 2009 as ‘‘the responsible provision
of evidence-based medication-related care for the purpose of
achieving deﬁnite outcomes that improve patients’ quality of
life’’ (Aburuz, 2015). EBPC evolves the application of the
current best up to date pharmacy research to provide effective
pharmaceutical services to patients. Like other health care
disciplines, implementation of EBPC mainly involves four
sequential steps (Weng et al., 2013): ﬁrst, framing a clear
question based on a clinical problem; second, searching for
relevant evidence in the literature; third, critically appraising
the validity of contemporary research; and fourth, applying
the ﬁndings to clinical decision-making.4. Discussion
From the literature review results it is clear that pharmaceuti-
cal care achieves a brilliant and innovative step in improving
the pharmacy practice to be more professional and effective
health care service. Changing practice from dispensing
to care providing system requires major changes in education
and training of the pharmacists that should be started early
from undergraduate level and continues throughout their
carrier.
Commitment and dedication of the pharmacists toward self
improvement and professionalism should be enforced and
encouraged since this will build up the future of the pharmacy
practice.
As any other health care discipline to be effective, pharma-
ceutical care needs to be evidence-based practice that is sys-
temic, well organized and updated. Being systemic implies
input, process and output. This ﬂow will also be subjected to
continuous corrections and modiﬁcations through feedback
step (pharmacists need to measure and monitor their contribu-
tion to health care for the ultimate beneﬁt of the patient). In
order to ensure standards of practice, pharmacists must be
willing to assess their knowledge and audit their practice to
determine the effectiveness of their interventions.
Evidence-based pharmaceutical care is a dynamic daily
practice that is updated according to new and emerging evi-
dence of high quality research and this represents the feedback
loop in this system.
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be subdivided into direct services that are provided directly
to the patient (ex. patient counseling) and indirect services like
any other pharmacy service that eventually will help the
patient (ex. therapeutic drug monitoring).
4.1. Example
In the anti-coagulation clinic the pharmacist is in direct contact
with the patients who are treated with warfarin. Pharmacists
are using written brochures to counsel the patients about the
proper use of warfarin but during the routine patient satisfac-
tion survey it had been noticed that some patients still do not
understand the basic information regarding warfarin use.
Now we have identiﬁed the problem, the root cause analysis
would be a good option or we can use the PICO method. The
next step is to review the literature to ﬁgure out the best evi-
dence based approach to be applied in order to achieve effec-
tive and convenient patient counseling. By literature search it
was found that there is evidence suggesting that weekly sched-
uled phone consultations increased awareness regarding warfa-
rin use and this resulted in decreased risk of hospitalization for
an adverse event associated with anticoagulation (Ibrahim and
Saber-Ayad, 2013). Consequently the pharmacy team decided
to apply the weekly phone consultations as warfarin counsel-
ing tool in addition to the conventional written (warfarin
booklet) educational brochures, and to follow the effect of
the new counseling program on the proper usage and under-
standing of warfarin using patient satisfaction measurement
tool. In this example evidence-based approach is used to pro-
vide pharmaceutical care to patient on warfarin.
Implementation of EBPC can improve the quality of the
pharmaceutical care services and encourage the pharmacists
to be involved in the health care systems as both practitioners
and researchers. Barriers to the implementation of the use of
evidence in clinical decision-making can generally be summa-
rized as problems in identifying, assessing, interpreting, and
applying best evidence to practice.
Some potential barriers may hinder the implementation of
an evidence base approach; these barriers can be categorizedas personal or environmental factors. Personal factors include:
Attitude and perception toward EBPC, time (due to a heavy
clinical load), basic knowledge, skills in critical appraisal, skills
in literature searching, clinical incorporation. Environmental
factors are those barriers related to system adopted by the
health institution like lack of support and reward, inadequate
library and evidence based resources and lack of specialized
training courses (Weng et al., 2013).
5. Conclusion
Health care interventions can no longer be based on opinion or
individual experience alone. Scientiﬁc evidence, built up from
good quality research, is used as a guide, and adapted to each
individual patient’s circumstances. As a new innovative con-
cept evidence-based pharmaceutical care seems promising
practice to improve the quality of the pharmaceutical care.
We encourage all health system pharmacists to adapt, dissem-
inate and promote this new concept to improve the pharmacy
profession. More focused studies are needed to establish and
market this concept as a daily pharmacy practice.
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